Product Program year 2025 Source: CMS Open Payments

Lariat RS

Device Cardiovascular

PDI 10840143904424

Open in the dashboard

General payments

$90,388

93 payments

Research payments

$191,237

120 payments

Through program year 2025, $90,388 in general payments and $191,237 in research payments were reported against Lariat RS (Cardiovascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $2,397 31
2024 General $67,799 37
2024 Research $10,664 8
2023 General $20,192 25
2023 Research $180,573 112

Breakdown

Who paid General payments · program years 2023–2025
  1. Atricure, Inc. $90,388 93 payments
Top recipients General payments · program year 2025
  1. Dhanunjaya Lakkireddy Clinical Cardiac Electrophysiology · Kansas City, KS $408 17% · 4 payments
  2. Devi Nair Clinical Cardiac Electrophysiology · Jonesboro, AR $378 16% · 3 payments
  3. Abdi Rasekh Clinical Cardiac Electrophysiology · Houston, TX $326 14% · 2 payments
  4. Vimal Nanavati Interventional Cardiology · National City, CA $251 10% · 2 payments
  5. Dilip Mathew Clinical Cardiac Electrophysiology · Sarasota, FL $219 9% · 2 payments

The top 5 of 21 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Cardiac Electrophysiology Internal Medicine $1,808 75% · 12 practitioners
  2. Interventional Cardiology Internal Medicine $251 10% · 1 practitioner
  3. Internal Medicine $155 6% · 1 practitioner
  4. Cardiovascular Disease Internal Medicine $57 2% · 1 practitioner
  5. Nurse Anesthetist, Certified Registered $49 2% · 2 practitioners

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $524 22% · 4 recipients
  2. Kansas $408 17% · 1 recipient
  3. Arkansas $378 16% · 1 recipient
  4. California $306 13% · 4 recipients
  5. Florida $244 10% · 2 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

93 general · 120 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record